The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Dysbiosis of Gut, But Not Ocular Microbiome, Associated with Sjögren’s Syndrome

Dysbiosis of Gut, But Not Ocular Microbiome, Associated with Sjögren’s Syndrome

July 11, 2016 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

iStock_TestTubes_Generic_500x270The healthy human intestinal microbiome is characterized by a balance between niche diversity and a relative abundance of members of the Bacteroidetes and Firmicutes phyla. Increasingly, research has revealed that this balance influences health and disease, and recently, evidence has accumulated to suggest that the microbiome may also play a role in tissue-specific autoimmunity. This year, Sjögren’s syndrome was added to the list of autoimmune conditions that are associated with intestinal dysbiosis. Specifically, researchers have revealed that patients with Sjögren’s syndrome have a dysbiotic intestinal microbiome that is characterized by a low relative abundance of commensal bacteria and a high relative abundance of potentially pathogenic genera. This dysbiosis is associated with worse ocular mucosal disease in patients with Sjögren’s syndrome, as well as a mouse model of Sjögren’s syndrome.

You Might Also Like
  • Volatility of the Gut Microbiome Tied to IBD
  • The Gut Microbiome Influences Postmenopausal Bone Loss
  • Gut-on-a-Chip Provides Insight into Microbiome & Intestinal Inflammation
Also By This Author
  • New Study Examines Pregnancy Risk Factors for Patients with Lupus

Cintia S. de Pavia, MD, PhD, assistant professor of ophthalmology at Baylor College of Medicine in Houston, and colleagues published the results of their microbiome analysis online on April 18 in Scientific Reports. They began their investigation in a validated mouse dry eye model with features of Sjögren’s syndrome. The mice were exposed to a desiccating stress (DS) environment, and the researchers measured the effect of DS on the intestinal microbiome of the mice. They compared those results with those of mice that received a cocktail of oral antibiotics for 14 days prior to and during exposure to DS. The investigators found that mice that received antibiotic treatment plus DS had less microbiome diversity than did mice that received DS alone. Additionally, the mice in the antibiotics-plus-DS group had greater goblet cell loss and an increased number of CD4+ T cells infiltrating the conjunctival epithelium than did mice that received DS alone. The researchers concluded from their results that although DS stress alone could cause a significant increase in Proteobacteria, oral antibiotics plus DS resulted in extreme changes in the gut microbiota.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Based on these mouse data, the investigators initiated a pilot study comparing the microbiome of the conjunctiva, tongue and stool of patients with Sjögren’s syndrome to the microbiome of healthy control subjects. They found that the stool from patients with Sjögren’s syndrome had greater relative abundances of Pseudobutyrivibrio, Escheria/Shigella, Blautia and Streptococcus and a lesser abundance of Bacteroides, Parabacteroides, Faecalibacterium and Prevotella relative to controls. Although the investigators found differences between the control and Sjögren’s syndrome groups in the stool and tongue microbiome, they found no differences in the conjunctival microbiome.

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: antibiotics, eye, gut microbiome, Microbiome, Sjögren's syndrome

You Might Also Like:
  • Volatility of the Gut Microbiome Tied to IBD
  • The Gut Microbiome Influences Postmenopausal Bone Loss
  • Gut-on-a-Chip Provides Insight into Microbiome & Intestinal Inflammation
  • The Microbiome’s Role in Inflammatory Arthritis

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)